Related Experiment Video
Updated: Aug 8, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Infectious imaging with indium-111-labeled nonspecific polyclonal human immunoglobulin
W A Wegener1, M G Velchik, D Weiss
1Department of Radiology, University of Pennsylvania, Philadelphia 19104.
Insights
Indium-111 labeled immunoglobulin G (111In-IgG) shows promise as a superior imaging agent for detecting focal infections and inflammation. This study confirms its effectiveness and practical advantages over other imaging methods.
Area of Science:
- Nuclear Medicine
- Diagnostic Imaging
- Immunology
Background:
- Nonspecific polyclonal immunoglobulin G (IgG) labeled with Indium-111 (111In-IgG) has demonstrated potential for infection and inflammation detection.
- Previous reports suggest 111In-IgG is comparable to antigen-specific antibodies in early imaging (within 24 hours).
Purpose of the Study:
- To evaluate the clinical utility and diagnostic accuracy of 111In-IgG in a Phase II study.
- To compare the efficacy of 111In-IgG with established imaging agents like 67Ga-citrate and 111In-labeled leukocytes.
Main Methods:
- A Phase II clinical study involving 15 patients with suspected focal infection or inflammation.
- Diagnostic confirmation through pathological examination, clinical assessment, laboratory results, and other imaging modalities.
- Analysis of imaging results for accuracy, including false-positives and false-negatives.
Main Results:
- 111In-IgG demonstrated high accuracy in identifying focal infection/inflammation.
- The study reported 10 confirmed positives and 4 confirmed negatives, with no false-positive results.
- One potential false-negative case was noted in suspected aspiration pneumonia.
Conclusions:
- 111In-IgG is a valuable imaging agent for detecting infection and inflammation.
- It offers practical advantages over 67Ga-citrate and 111In-labeled leukocytes.
- Further research supports the use of 111In-IgG in clinical practice for diagnosing infectious and inflammatory conditions.
Abstract:
Nonspecific polyclonal immunoglobulin (IgG), prepared from pooled human serum gamma globulin and labeled with 111In has been reported to be equivalent to antigen-specific antibody in the detection of focal infection or inflammation during the first 24 hr after injection. We describe our experience in a Phase II clinical study using 111In-IgG in 15 patients (8 males, 7 females) ranging from 26 to 80 (mean = 50) yr of age with suspected focal infection/inflammation. Pathologic confirmation was obtained in 5/15 cases. A combination of clinical course, laboratory results, and other imaging procedures were used to categorize the other 10 patients. One possible false-negative involved a presumed aspiration pneumonia in a patient with a history of aspiration, bibasilar infiltrates on chest film, and no other identified source of infection. Otherwise, there were 10 confirmed positives, 4 confirmed negatives, and no false-positives. Our findings confirm earlier reports that 111In-IgG may be a superior imaging agent for infection/inflammation with practical advantages over 67Ga-citrate and 111In-labeled leukocytes.
More Related Videos
Related Concept Videos
Immunogold Electron Microscopy
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

